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Opitz G/BBB syndrome (OS) is a congenital defect characterized by hypertelorism and hypospadias, but additional midline malformations
are also common in OS patients. X-linked OS is caused by mutations in the ubiquitin ligase MID1. In chick, MID1 is involved in left–right
determination: a mutually repressive relationship between Shh and cMid1 in Hensen’s node plays a key role in establishing the avian left–right
axis. We have utilized our existing knowledge of the molecular basis of avian L/R determination to investigate the possible existence of
functional redundancy betweenMID1 and its close homologueMID2. The expression of cMid2 overlaps with that of cMid1 in the node, and we
demonstrate that MID2 can both mimic MID1 function as a right side determinant and rescue the laterality defects caused by knocking down
endogenous MID proteins in the node. Our results show that MID2 is able to compensate for an absence in MID1 during chick left–right
determination and may explain why OS patients do not suffer laterality defects despite the association between midline and L/R development.
The demonstration of functional redundancy between MID1 and MID2 in the node provides supports for the hypothesis that partial functional
redundancy between MID proteins in other developing structures contributes to the wide variability of OS phenotype.
D 2004 Elsevier Inc. All rights reserved.
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Introduction identical MID1 mutations (Cox et al., 2000), suggestingX-linked Opitz G/BBB syndrome (OS; OMIM 300000
and 145410), characterized by defective midline develop-
ment, is associated with mutations in MID1 (Quaderi et al.,
1997). The principal features of OS are hypertelorism
(abnormally wide distance between the eyes) and hypo-
spadias (abnormal positioning of the opening of the
urethra), but other midline defects, such as tracheoesopha-
geal fistulas, cardiac malformations, and CNS defects, are
also common in OS patients (De Falco et al., 2003). There
is considerable clinical variability in the presentation of OS,
even among male patients from the same family sharing0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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Although OS is a rare disease, research into MID1 function
is of significant clinical interest as MID1 represents one of
the few genes associated with either Mendelian inherited
mental retardation or cleft lip and/or palate. MID1 is a
microtubule-associated member of the RBCC family of
proteins (also known as the TRIM family) characterized by
an N-terminal tripartite motif consisting of a RING finger,
one or two B-boxes, and a coiled-coil domain (Reymond et
al., 2001). In common with other RING finger proteins
(Joazeiro and Weissman, 2000), MID1 is a ubiquitin ligase:
it specifically targets the microtubule-associated pool of the
catalytic subunit of phosphatase 2A (PP2Ac) for degrada-
tion by binding to its alpha 4 (a4) regulatory subunit
(Trockenbacher et al., 2001). MID2, closely related to
MID1, is also microtubule-associated (Buchner et al., 1999;
Perry et al., 1999) and able to bind a4 (Short et al., 2002;277 (2005) 417–424
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that the variability of the OS phenotype can be attributed to
partial functional redundancy between MID proteins in
tissues where their expression domains overlap (Short et
al., 2002).
Improper development of the axial midline in vertebrates
can cause both midline and laterality defects, and the
involvement of the Sonic Hedgehog (SHH) and Nodal
pathways in both midline and left–right (L/R) development
provides a molecular basis for this association (Roessler and
Muenke, 2001). The hypertelorism characteristic of OS is
reminiscent of the hypertelorism displayed by patients with
mutations in PTCH and GLI3, two known antagonists of the
SHH pathway (Hahn et al., 1996; Johnson et al., 1996;
Vortkamp et al., 1991). This observation suggests that MID1
may act as an intracellular antagonist of the SHH pathway,
prompting us to investigate whether MID1 plays a role in L/
R determination. We have previously shown that the chick
MID1 orthologue, cMid1, is involved in establishing the
avian left–right (L/R) axis (Granata and Quaderi, 2003). L/R
determination in chick involves the establishment of
asymmetric gene expression in Hensen’s node (Capdevila
et al., 2000; Mercola and Levin, 2001): a mutually repressive
interaction between Shh and cMid1 maintains asymmetric
gene expression in the node by restricting Shh to the left, and
cMid1 to the right, of Hensen’s node (Granata and Quaderi,
2003). The distinct signaling pathways on the left and right
sides of the node transmit L/R information to the lateral plate
mesoderm (LPM) and then on to the organ primordia,
resulting in asymmetric morphogenesis (Capdevila et al.,
2000; Mercola and Levin, 2001). Incorrect patterning of the
L/R axis is potentially life-threatening as it results in the
abnormal positioning and patterning of the visceral organs
(Capdevila et al., 2000; Mercola and Levin, 2001).
Here, we have used the well-characterized molecular
cascades involved in avian L/R determination to address the
issue of functional redundancy between MID1 proteins. We
show that cMid2 expression overlaps with that of cMid1 in
Hensen’s node and that MID2 can mimic MID1 as a right
side determinant. Furthermore, we find that MID2 is able to
rescue the L/R patterning defects caused by knocking down
endogenous MID proteins expressed in Hensen’s node. The
demonstration of functional redundancy between MID
proteins during avian L/R determination supports the
hypothesis that the variability of the OS phenotype can be
attributed to partial functional redundancy between MID
proteins. Our results also suggest a possible explanation for
the absence of laterality defects associated with OS.Materials and methods
Cloning of 5V cMid2 cDNA
5V Mid2 cDNA sequences were cloned from poly(A)+
RNA derived from stage 13–15 chick embryos by 5VRACE–PCR using the SMARTTM RACE cDNA amplifi-
cation kit (Invitrogen) and following manufacturer’s
instructions. The cMid2-specific primer used (cMid2.race3)
has the following sequence: 5V-TCG CTG AGC GAC GCC
ACT TGG TGA TCC-3V. RACE amplification products
were cloned with the TOPO-TA cloning kit for sequencing
(Invitrogen) following supplier’s recommendations.
Expression constructs and antisense morpholinos
The mouse Mid2 coding region was PCR-amplified
using BamHI and ClaI tailed primers and cloned into the
BamHI/ClaI sites of the pCAB expression vector to
generate pCAB.mMid2. The DR expression construct
contains the portion of the cMid1 cDNA coding for
residues 73–667 cloned into the BamHI/ClaI sites of the
pCAB expression vector. The B-box expression construct
contains the portion of the cMid1 cDNA coding for
residues 111–165 cloned into the BamHI/ClaI sites of the
pCAB expression vector. The DC expression construct
contains the portion of the cMid1 cDNA coding for
residues 1–307 cloned into the BamHI/ClaI sites of the
pCAB expression vector. All the pCAB expression
constructs detailed above contain an IRES-GFP cassette.
pCAB.cMid1 and the morpholinos cMid1.mo (renamed
cMid.MO) and control.mo have been previously described
(Granata and Quaderi, 2003).
Embryo culture and electroporations
Chick embryos were staged in accordance with
Hambuger and Hamilton (1951). A modified EC culture
technique was used to transfer stage 4 embryos, dorsal
side up with the vitelline membrane removed, into a
small electroporation chamber containing a positive
platinum electrode in its base. Embryos were positioned
such that this electrode was on the left or on the right of
Hensens node, as appropriate. pCAB.mMid2, pCAB.c-
Mid1, pCAB.DR, pCAB.B-box, pCAB.DC, and
pCAB.GFP were applied using a glass micropipette at
2 Ag/Al in 0.1% fast green for visualization. cMid.MO
and control.MO were applied at 1 mM in 0.1% fast green
for visualization. Electroporations were performed by
placing a negative tungsten electrode over the DNA (or
morpholino) solution and applying four square pulses (5
V, 50 ms) using an Intracept TSS10 dual-pulse isolated
stimulator (Intracel, UK). Embryos were then grown
ventral side up as EC cultures (Chapman et al., 2001)
until the appropriate stage. GFP/fluorescein fluorescence
was used to monitor the position and efficiency of
electroporation.
Whole-mount in situ hybridization and immunostaining
A 758-bp cMid2 5V RACE clone was used as a template
for riboprobe generation. Whole-mount in situ hybrid-
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techniques.Results
A single EST representing the chick MID2 orthologue,
cMid2, was identified in the BBSRC ChickEST Database
(www.chick.umist.ac.uk; clone ID ChEST660F7); how-
ever, this clone covers only part of the Mid2 coding
region and lacks both the 5V and 3V ends. Screening of a
stage 12–14 chick embryo cDNA library using the cMid2
EST clone only identified clones representing cMid1. 5V
RACE PCR was performed on cDNA derived from stage
13–15 chick embryos, and clones covering the cMid2 5V
coding region and UTR were recovered. This 5V cMid2
cDNA sequence has been deposited in GenBank (acces-
sion number AY546077). We were unable to clone the 3V
cMid2 coding region. Whole-mount in situ RNA hybrid-
ization was used to determine the cMid2 expression pattern
during early development (Fig. 1). Comparison of the
cMid1 and cMid2 expression patterns shows that they are
both expressed symmetrically in Hensen’s node at stage 4
(Figs. 1B, C). cMid2 expression is not detected before this
stage. cMid1 is first detected at stage 2 in a small,
symmetrical anterior domain (Fig. 1A). By stage 3, cMid1
expression is more intense and has expanded to form a
crescent-shaped domain (Fig. 1E). cMid1/2 expression is
down-regulated on the left side of the node by stage 5 (Fig.
1D; Granata and Quaderi, 2003), and this asymmetricFig. 1. Comparison of cMid2 and cMid1 expression during early development. (A
anterior crescent-shaped domain at stage 3. (B) cMid2 expression is first seen in
expressed in Hensen’s node and in a crescent-shaped ectodermal domain at stage 4
(F) cMid2 expression in the node is still asymmetric at stage 7. (G) By stage 8, cM
extraembryonic tissue. A transverse section through the neural plate, at the level of
and lateral plate mesoderm at stage 8. Transverse sections through the neural plate
inserts of the node show the small changes in gene expression. Embryos are shoexpression is evident until stage 7 (Fig. 1F; Granata and
Quaderi, 2003). The anterior crescent-shaped cMid1 expres-
sion domain (Fig. 1C; Granata and Quaderi, 2003) is not
shared by cMid2 (Figs. 1B, D), and only cMid2 is expressed
in the anterior primitive streak and extraembryonic tissue
(Figs. 1B, G). At stage 8, both cMid1 and cMid2 are
expressed in the neural plate, but cMid1 has a more
posterior limit of expression (Figs. 1G and H). cMid1
expression is excluded from the most medial (ventral)
region of the neural plate (Fig. 1H), but cMid2 expression is
at a uniform level throughout the width of the neural plate
(Fig. 1G). cMid1 expression in the somites and lateral plate
mesoderm (Fig. 1H) is not shared by cMid2 (Fig. 1G).
We have previously shown that misexpressing MID1 on
the left side of Hensen’s node results in ectopic expression
of right pathway markers (e.g., Fgf8; Boettger et al., 1999)
and repression of left pathway markers (e.g., Shh; Levin et
al., 1995) (Granata and Quaderi, 2003). To investigate
whether misexpression of MID2 could also disrupt normal
L/R molecular asymmetries in an analogous manner, we
focally electroporated an expression vector carrying a
mouse Mid2-IRES-GFP insert (pCAB.mMid2) into the left
side of Hensen’s node in stage 4 embryos (Fig. 2A). Mouse
Mid2 was used as we were unable to clone the entire
cMid2 coding region. Embryos were cultured to stage 6
and then assayed for either Shh or Fgf8 expression.
Embryos electroporated with pCAB.mMid2 showed an
absence of Shh expression in the node (n = 5/5; 100%; Fig.
2C) or bilateral Fgf8 expression in the node (n = 6/7; 86%;
Fig. 2E). Control embryos electroporated with a vector) cMid1 expression is first detected at stage 2. (E) cMid1 is expressed in an
Hensen’s node and the anterior primitive streak at stage 4. (C) cMid1 is
. (D) By stage 5, cMid2 expression is confined to the right side of the node.
id2 is down-regulated in the node. Expression is seen in the neural plate and
the black line, is shown. (H) cMid1 is expressed in the neural plate, somites,
and somites, at the level of the black lines, are shown. High magnification
wn dorsal side up. L, left; R, right.
Fig. 2. MID2 acts as a right-side determinant. (A) A Mid2 expression vector was focally electroporated into the left side of the node in stage 4 embryos. (B)
Control GFP electroporations have no effect on Shh expression. (C) Mid2 electroporations result in a loss of Shh expression in the node. (D) Control GFP
electroporations have no effect on Fgf8 expression. (E) Mid2 electroporations result in ectopic Fgf8 expression on the left side of the node. The node is
outlined in black. High magnification inserts of the node highlight the small changes in gene expression. Embryos are shown dorsal side up. L, left; R, right.
A. Granata et al. / Developmental Biology 277 (2005) 417–424420expressing only GFP (pCAB.GFP) showed no change in
Shh (n = 4/4; Fig. 2B; also Granata and Quaderi, 2003) or
Fgf8 (n = 4/4; Fig. 2D; also Granata and Quaderi, 2003)
expression. These results indicate that MID2 is able to
mimic MID1 function as a right side determinant, with
respect to Shh and Fgf8 expression, when misexpressed on
the left side of Hensen’s node.
Knocking down right-sided MID1 expression in the node
using an antisense morpholino, cMid1.mo, inhibits the
expression of right pathway markers and induces the ectopic
expression of the left pathway on the right side of the
embryo (Granata and Quaderi, 2003). cMid1.mo was
designed to target the first 25 coding nucleotides of the
cMid1 cDNA sequence. Comparison of 5V cMid1 and
cMid2 sequences shows that there are only 2/25 mismatches
in this region between cMid2 and cMid1.mo (Fig. 3). At
least 4/25 mismatches are required to prevent efficient
binding of a morpholino to a target sequence (www.gene-
tools.com). Therefore, it is probable that cMid1.mo (from
now on referred to as cMid.MO) binds to both cMid1 and
cMid2, thereby blocking the translation of both MID
proteins. Consequently, the laterality defects caused by
focally electroporating cMid.MO into the node could be the
result of knocking down both MID1 and MID2 in the node,
rather than MID1 alone. If this is the case, and if MID1 and
MID2 are functionally redundant with respect to L/R
determination, overexpression of MID2 on the right side
of the node should be able to rescue the L/R defects caused
by cMid.MO treatment. If, however, there is no functional
redundancy between MID1 and MID2, overexpression of
MID2 should have no effect on the L/R defects caused by
cMid.MO treatment. In order to investigate whether MID2,
in the absence of MID1, is sufficient for correct establish-
ment of the L/R axis, we have used the expression vectorFig. 3. 5V cMid1 and cMid2 sequences are highly conserved. There are only
2/25 mismatches in the first 25 coding nucleotides between cMid1 and
cMid2. The amino acid sequence is perfectly conserved in this region.pCAB.mMid2 to try and rescue the laterality defects caused
by treatment with cMid.MO. cMid.MO was focally electro-
porated into the right side of Hensen’s node at stage 4 (Fig.
4A). Embryos were cultured to stage 6, fixed, and assayed
for either Fgf8 or Shh expression. Fgf8 expression was
absent from the node (n = 5/5; 100%; Fig. 4B; also Granata
and Quaderi, 2003), and Shh was expressed bilaterally in the
node (n = 5/5; 100%; Fig. 4H; also Granata and Quaderi,
2003) in these embryos. No change in normal Fgf8 (n = 6/6;
100%; Fig. 4C; also Granata and Quaderi, 2003) or Shh (n =
5/5; 100%; Fig. 4I; also Granata and Quaderi, 2003)
expression was seen in embryos electroporated with a
control morpholino (control.MO). Co-electroporation of
pCAB.GFP and cMid.MO has the same effect as electro-
porations with cMid.MO alone. Co-electroporated embryos
show an absence of Fgf8 expression in the node (n = 4/5;
80%; Fig. 4D) and bilateral Shh expression in the node (n =
5/5;100%; Fig. 4J). However, co-electroporation of pCAB.
mMid2 with cMid.MO results in the rescue of the molecular
laterality defects seen with electroporation of cMid.MO
alone: Fgf8 expression is restricted to the right side of the
node (n = 8/10;80%; Fig. 4E), while Shh expression is
restricted to the left side (n = 8/9;89%; Fig. 4K). Co-
electroporation of pCAB.mMid2 and control.MO on the
right side of the node in stage 4 embryos results in right-
sided Fgf8 expression (n = 4/4; 100%; Fig. 4F) and left-
sided Shh expression (n = 4/4; 100%; Fig. 4L) in the node at
stage 6, indicating that overexpression of MID2 on the right
side of the node in the presence of normal background levels
of MID1/2 does not disrupt correct L/R determination. The
typical extent of overlap between pCAB.cMid2 (or
pCAB.GFP) expression and cMid.MO (or control.MO)
transfection at stage 6 in co-electroporated embryos is
shown (Fig. 4G). Co-electroporations using pCAB.cMid1,
rather than pCAB.cMid2, with cMid.MO also showed
normal Fgf8 and Shh expression, indicating that the
presence of either MID protein in the node is sufficient
for the correct establishment of the L/R axis (data not
shown).
MID1 and MID2 are members of the RBCC family of
proteins. In addition to the RING finger, B-boxes, and
coiled-coil domain that characterize this family, the MID
Fig. 4. MID2, in the absence of MID1, is sufficient for correct L/R patterning. (A) Expression constructs and morpholinos were electroporated into the right
side of the node at stage 4. (B) Electroporation of cMid.MO results a loss of Fgf8 expression in the node. (C) Electroporation of control.MO has no effect on
Fgf8 expression. (D) Co-electroporation of pCAB.GFP and cMid.MO results in a loss of Fgf8 expression in the node. (E) Co-electroporation of pCAB.mMid2
and cMid.MO results in the rescue of right-sided Fgf8 expression in the node. (F) Co-electroporation of pCAB.mMid2 and control.MO does not disrupt normal
Fgf8 expression in the node. (G) Overlap between cMID.MO and pCAB.mMid2 in stage 6 co-electroporated embryos. (H) Electroporation of cMid.MO results
in ectopic Shh expression on the right side of the node. (I) Electroporation of control.MO has no effect on Shh expression. (J) Co-electroporation of pCAB.GFP
and cMid.MO results in ectopic Shh expression on the right side of the node. (K) Co-electroporation of pCAB.mMid2 and cMid.MO results in the normal
confinement of Shh expression to the left side of the node. (L) Co-electroporation of pCAB.mMid2 and control.MO does not disrupt normal Shh expression in
the node. The node is outlined in black. High magnification inserts of the node highlight the small changes in gene expression. Embryos are shown dorsal side
up. L, left; R, right.
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unknown function (B30.2 domain) shared by a subset of
RBCC proteins (Reymond et al., 2001). Human MID1 and
MID2 show an overall level of 84% similarity and 77%
identity at the amino acid level (Buchner et al., 1999).
Experiments performed in vitro have provided insight into
the roles of the various domains of the MID proteins. Most
OS-causing MID1 mutations lie within the C-terminal and
are associated with a loss of MID1 microtubule local-
ization, indicating that microtubule association is mediated
through the C-terminal and is essential for correct MID1
function (Cainarca et al., 1999; Cox et al., 2000; De Falco
et al., 2003; Gaudenz et al., 1998; Quaderi et al., 1997;
Schweiger et al., 1999). The coiled-coil domain has been
shown to mediate MID protein dimerization: both MID1
and MID2 are able to homodimerize, but there is
conflicting evidence regarding the ability of MID proteins
to heterodimerize (Cainarca et al., 1999; Short et al.,
2002). The a4 regulatory subunit of PP2A selectively
binds to the B-box 1 sequence of both MID1 and MID2
and does not bind to B-box sequences derived from any
other RBCC proteins (Liu et al., 2001; Short et al., 2002;
Trockenbacher et al., 2001). A variety of RING finger
containing proteins has been shown to act as E3 ubiquitin
ligases by binding to both E2 ubiquitin-conjugating
enzymes, via the RING finger domain, and the target
protein destined for degradation (Joazeiro and Weissman,
2000). Although an E2 enzyme has yet to be identified that
binds to MID proteins, the ubiquitination and subsequentdegradation of PP2Ac are seen to be MID1-dependent
(Trockenbacher et al., 2001).
The vast majority of OS-associated mutations disrupt the
MID1 C-terminus, leaving the N-terminal tripartite motif
intact. Conflicting theories exist as to whether OS is caused
by gain-of-function mutations in MID1, through deregulated
activity of the intact tripartite motif (Schweiger et al., 1999)
or by loss-of-function mutations in MID1 (Cox et al., 2000).
We have generated a MID1 expression construct lacking the
C-terminus (pCAB.DC; Fig. 5) in order to test in vivo
whether the isolated MID1 tripartite motif behaves as a
gain-of-function isoform. We have also generated two
further MID1 deletion constructs (pCAB.DR and
pCAB.B-box; Fig. 5) to test whether the in vivo function
of MID protein domains is consistent with the observed in
vitro biochemical function. If the in vitro model for MID
function is correct, we can predict that both these constructs
will behave as dominant negatives when electroporated into
MID-expressing cells as they should both block the
targeting of PP2Ac for ubiquitin-mediated degradation: the
DR construct blocks recruitment of an E2 enzyme, and the
B-box construct blocks binding to a4. The DR construct
lacks the RING finger domain (Fig. 5). This construct
should be able to bind a4 (through B-box 1) and localize to
microtubules (through the C terminal domain). However, as
this construct lacks a RING finger, it is unable to bind to an
E2 enzyme. In vitro binding studies have shown that the
dnakedT B-box 1 sequence has a much greater affinity for a4
than the B-box 1 sequence in the context of a MID protein
Fig. 5. MID protein domains. Cartoon showing the content of the three MID1 deletion constructs.
A. Granata et al. / Developmental Biology 277 (2005) 417–424422(Trockenbacher et al., 2001). Overexpression of the B-box
construct into MID-expressing cells is predicted to out-
compete both MID1 and MID2 in binding a4 and, in
common with the DR construct, prevent the ubiquitination
and subsequent degradation of PP2Ac.
The cMid1 expression vector, pCAB.cMID1, was
focally electroporated into the right side of Hensen’s node
in stage 4 embryos (Fig. 6A). Embryos were cultured to
stage 6 and then assayed for either Fgf8 or Shh expression.
Fgf8 expression was confined to the right side of the node
(n = 4/4; 100%; Fig. 6B), while Shh expression was
confined to the left side of the node (n = 4/4; 100%; Fig.
6H). These results show that overexpressing MID1 within
the endogenous MID1/2 expression domain on the right
side of the node has no effect on normal L/R determi-
nation. Electroporation of DC into the right side of the
node in stage 4 embryos has no effect on normal L/R
patterning at stage 6, suggesting that DC is a loss-of-Fig. 6. Effect of MID1 deletion constructs on L/R patterning. (A) Expression co
Overexpression of cMid1 has no effect on Fgf8 expression in the node. (C) Express
B-box results in a loss of Fgf8 expression in the node. (E) Expression of DC does
the node at stage 5. (G) a4 expression is restricted to the right side of the node by s
node. (I) Expression of DR results in ectopic Shh expression on the right side of the
side of the node. (K) Expression of DC does not effect Shh expression in the no
highlight the small changes in gene expression. Embryos are shown dorsal side ufunction construct: Fgf8 expression is restricted to the right
(n = 12/12; 100%; Fig. 6E), and Shh expression is
restricted to the left (n = 9/9; 100%; Fig. 6K). Embryos
co-electroporated with DC and cMid.MO also show
normal Shh and Fgf8 expression (data not shown). These
results do not support a dominant negative role for the
MID1 tripartite motif and instead are consistent with OS
being a manifestation of loss-of-function mutations in
MID1.
Electroporation of the DR construct into the right side of
the node in stage 4 embryos results in defective L/R
patterning by stage 6: electroporated embryos lack Fgf8
expression in the node (n = 12/14; 86%; Fig. 6C) or have
bilateral Shh expression in the node (n = 14/16; 88%;
Fig. 6I). Similarly, embryos electroporated with the B-box
construct also lack Fgf8 expression in the node (n = 13/16;
81%; Fig. 6D) or have bilateral Shh expression (n = 16/18;
89%; Fig. 6J). These results are consistent with ournstructs were electroporated into the right side of the node at stage 4. (B)
ion of DR results in a loss of Fgf8 expression in the node. (D) Expression of
not effect Fgf8 expression in the node. (F) a4 is expressed symmetrically in
tage 6. (H) Overexpression of cMid1 has no effect on Shh expression in the
node. (J) Expression of B-box results in ectopic Shh expression on the right
de. The node is outlined in black. High magnification inserts of the node
p. L, left; R, right.
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endogenous MID function in a dominant negative manner
and support the in vitro model for MID1 domain functions.
These two constructs will provide a valuable alternative to
cMid.MO for investigating the consequences of blocking
MID function in other developing organ systems.
Given that correct MID function in vitro appears depend-
ent on association with a4, we have investigated whether a4
is expressed in Hensens node. Several EST clones represent-
ing the chick a4 orthologue were identified in the BBSRC
ChickEST Database (www.chick.umist.ac.uk; template
sequence 339799.6). EST clone ChEST463i11 was used as
a template to generate an antisense RNA probe for use in
whole-mount in situ hybridization. Weak a4 expression is
first seen on both sides of Hensens node at stage 4 (data not
shown). At stage 5, when cMid1 and cMid2 are already
confined to the right, a4 expression is still symmetric in the
node (Fig. 6F), but its expression is restricted to the right side
by stage 6 (Fig. 6G). Expression remains asymmetric at stage
7 and is down-regulated by stage 8 (data not shown).Discussion
The chick homologue of the Opitz syndrome gene,
cMid1, is involved in the establishment of asymmetric gene
expression in Hensen’s node: a key step in patterning the
avian L/R axis (Granata and Quaderi, 2003). We have
utilized our existing knowledge of the molecular pathways
involved in avian L/R determination to investigate whether
functional redundancy exists between MID proteins. We
have also used the L/R system to determine whether OS is
associated with loss-of-function or gain-of-function MID1
mutations and whether MID1 function in vivo is consistent
with in vitro biochemical data.
cMid1 and cMid2 are co-expressed on the right side of
Hensen’s node between stages 5 and 7. We have shown that
when misexpressed on the left side of the node, MID2 can
mimic MID1 in repressing endogenous Shh expression and
inducing ectopic Fgf8 expression. Furthermore, we show that
overexpression of MID2 on the right side of the node can
rescue the laterality defects caused by treatment with
cMid.MO. The antisense morpholino cMid.MO was origi-
nally designed to target the first 25 coding nucleotides of the
cMid1 sequence, and it was assumed that the L/R patterning
defects caused by cMid.MO were a result of knocking down
MID1 alone (Granata and Quaderi, 2003). We now show that
the expression of cMid1 in the node is shared by cMid2 and
that there are only two mismatches between cMid1 and
cMid2 in the 5V region targeted by cMid.MO. As at least 4/25
mismatches are recommended to prevent binding of antisense
morpholinos to their target sequences and up to 11/25
mismatches are used in practice (Sheng et al., 2003), it is
likely that cMid.MO binds to both cMid1 and cMid2. We
have been unable to raise antibodies that reliably detect chick
MID proteins and so are unable to test directly whethercMid.MO blocks the translation of either endogenous MID1
or MID2. However, the set of control electroporations
performed strongly indicates that the laterality defects caused
by cMid.MO are the specific result of knocking down
endogenous MID1/2 expression in the node and that the
rescue of these defects is through the specific action of
exogenous MID2.
The DC MID1 deletion construct, containing the N-
terminal tripartite domain but lacking the C-terminus, is
representative of the vast majority of MID1 mutations
associated with OS. DC acts as a nonfunctional MID1
construct, indicating that OS is likely to be a manifestation
of loss-of-function, rather than gain-of-function, mutations
in MID1. The observation that the DR and B box constructs
both block endogenous MID activity in a dominant negative
manner indicates that the in vivo function of the MID1
protein domains is consistent with their biochemical activity
observed in vitro. Furthermore, the results of blocking MID
function using the dominant negative DR and B box
constructs are consistent with the results obtained from
blocking MID function using antisense morpholinos.
The demonstration of functional redundancy between
MID proteins during avian L/R determination suggests that
functional redundancy between MID proteins could exist in
other systems where they are co-expressed. It is notable that
we have used mouse MID2 to compensate for an absence of
chick MID1, as this indicates that MID function is well
conserved both between species (mouse and chick) and
homologues (MID1 and MID2). Our results support the
hypothesis that the phenotypic variability in OS can be
attributed to functional redundancy between MID1 and
MID2, although further studies are required to prove this
hypothesis. In addition to the node, we have seen partial
overlap between cMid1 and cMid2 expressions in the
anterior neural plate. However, we have also identified
regions, such as the primitive streak and the developing
somites, where only a single cMid gene is expressed,
indicating that there are structures in the developing embryo
where MID1 and MID2 have a nonredundant function.
Further studies will focus on examining whether functional
redundancy between MID proteins exists in developing
midline structures affected in OS.
Although there is an association between midline and
laterality defects (Danos and Yost, 1995, 1996; Lohr et al.,
1997; Roessler and Muenke, 2001; Yost, 1998), L/R defects
are not a typical feature of OS. This may reflect the fact that
the mechanisms of early L/R determination are poorly
conserved between species, and MID1 is not required for
patterning the human L/R axis (Capdevila et al., 2000; Levin,
2003). However, our results indicate that the absence of
laterality defects in OS patients does not necessarily preclude
the involvement of MID1 in human L/R determination: it is
possible that MID2 might compensate for an absence of
MID1 during the establishment of the L/R axis in individuals
with OS. A recent study suggests that similarities in the
anatomy of early embryos, rather than taxonomic similarities,
A. Granata et al. / Developmental Biology 277 (2005) 417–424424may be a key factor in shared mechanisms of early L/R
patterning among species (Fischer et al., 2002):Fgf8 is a right
determinant in chicks and rabbits, both of which develop as a
flat blastodisc, but is a left determinant in mouse, although
both mice and rabbits are mammals (Boettger et al., 1999;
Fischer et al., 2002; Meyers and Martin, 1999). As human
embryos also develop as a flat blastodisc, factors found to
play an early role in L/R determination in chick or rabbit, such
as the MID1 proteins, may have a conserved function in
establishing the human L/R axis.Acknowledgments
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